Suicidality as rare adverse event of antidepressant medication: Report from the AMSP multicenter drug safety surveillance project

Journal of Clinical Psychiatry

Volumn 71, Issue 10, 2010, Pages 1293-1307

  Stübner, Susanne ^a   Grohmann, Renate ^a   Von Stralendorff, Irmela ^a   Rüther, Eckart ^a,c   Möller, Hans Jürgen ^a   Müller Oerlinghausen, Bruno ^b   Engel, Rolf R ^a   Horvath, Andreas ^d   Greil, Waldemar ^a,d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Drug Commn of the Ger Med Assoc   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Psychiatric Hospital Kilchberg   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; SEROTONIN ANTAGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DRUG SURVEILLANCE PROGRAM; DRUG USE; DYSTONIA; FEMALE; HEALTH SURVEY; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; RESTLESSNESS; RISK FACTOR; SIDE EFFECT; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; SEROTONIN UPTAKE INHIBITORS; SUICIDAL IDEATION; SUICIDE;

EID: 78149287608     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05912blu     Document Type: Article

References (38)

1. Möller H-J. Is there evidence for negative effects of antidepressants on suicidality in depressive patients? a systematic review. Eur Arch Psychiatry Clin Neurosci. 2006;256(8):476-496.doi:10.107/s0406-06-0689-8 PubMed
2. Damluji NF, Ferguson JM. Paradoxical worsening of depressive symptomatology caused by antidepressants. J Clin Psychopharmacol. 1988;8(5): 347-349.doi:10.1097/04714-19810-07 PubMed
3. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry. 1990;147(2):207-210. PubMed
4. Rouillon F, Phillips R, Serrurier D, et al. Recurrence of unipolar depression and efficacy of maprotiline. Encephale. 1989;15(6):527-534. PubMed
5. Ströbel C, Grohmann R, Rüther E, et al. Stationäre UAW-Erfassung: Antidepressiva. In: Grohmann R, Rüther E, Schmidt LG, eds. Unerwünschte Wirkungen von Psychopharmaka: Ergebnisse der AMÜP-Studie. 1st ed. Berlin, Germany: Springer; 1994:134-204.
6. Grohmann R, Ströbel C, Rüther E, et al. Adverse psychic reactions to psychotropic drugs: a report from the AMÜP study. Pharmacopsychiatry. 1993;26(3):84-93.doi:10.105/s-207-1014348 PubMed
7. Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004;363(9418):1341-1345.doi:10.1016/S0140-6736(04) 16043-1 PubMed
8. Whittington CJ, Kendall T, Pilling S. Are the SSRIs and atypical antidepressants safe and effective for children and adolescents? Curr Opin Psychiatry. 2005;18(1):21-25. PubMed
9. Healy D, Whitaker C. Antidepressants and suicide: risk-benefit conundrums. J Psychiatry Neurosci. 2003;28(5):331-337. PubMed
10. Culpepper L, Davidson JR, Dietrich AJ, et al. Suicidality as a possible side effect of antidepressant treatment. J Clin Psychiatry. 2004;65(6):742-749. doi:10.408/JCP.v65n0603 PubMed
11. Möller H-J, Baldwin DS, Goodwin G, et al. WPA Section on Pharmacopsychiatry. Do SSRIs or antidepressants in general increase suicidality? WPA section on pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci. 2008;258(suppl 3):3-23. PubMed
12. Soloff PH, George A, Nathan RS, et al. Paradoxical effects of amitriptyline on borderline patients. Am J Psychiatry. 1986;143(12):1603-1605. PubMed
13. Teicher MH, Glod CA, Cole JO. Dr Teicher and associates reply. Am J Psychiatry. 1990;147(12):1692-1693.
14. Hegerl U. Antidepressants and suicidality: risk-benefit analysis [in German]. Nervenarzt. 2007;78(1):7-14.doi:10.107/s015-06-2109-8 PubMed
15. Martinez C, Rietbrock S, Wise L, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ. 2005;330(7488):389.doi:10.136/bmj.30.748.389 PubMed
16. Fergusson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ. 2005;330(7488):396.doi:10.136/bmj.30.748.396 PubMed
17. Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160(4):790-792.doi:10.176/api.ajp.160.4.790 PubMed
18. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ. 2005;330(7488):385.doi:10.136/bmj.30.748.385 PubMed
19. Vanderburg DG, Batzar E, Fogel I, et al. A pooled analysis of suicidality in double-blind, placebo-controlled studies of sertraline in adults. J Clin Psychiatry. 2009;70(5):674-683.doi:10.408/JCP.07m0404 PubMed
20. Donovan S, Clayton A, Beeharry M, et al. Deliberate self-harm and antidepressant drugs: investigation of a possible link. Br J Psychiatry. 2000; 177(6):551-556.doi:10.192/bjp.17.6.51 PubMed
21. Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880.doi:10.136/bmj.b280 PubMed
22. Cipriani A, Barbui C, Geddes JR. Suicide, depression, and antidepressants. BMJ. 2005;330(7488):373-374.doi:10.136/bmj.30.748.373 PubMed
23. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23(9):1351-1375.doi:10.102/sim.1761 PubMed
24. Arzneimittelkommission der deutschen Ärzteschaft. SSRI und Suizidalität? Dtsch Arztebl. 2004;101:A2642.
25. Göder R, Friege L, Treskov V, et al. Association of paroxetine with suicide attempt in obsessive-compulsive disorder. Pharmacopsychiatry. 2000; 33(3):116-117.doi:10.105/s-20-797 PubMed
26. Grohmann R, Engel RR, Rüther E, et al. The AMSP drug safety program: methods and global results. Pharmacopsychiatry. 2004;37(suppl 1): S4-S11.doi:10.105/s-204-81505 PubMed
27. Grohmann R, Hippius H, Helmchen H, et al. The AMÜP study for drug surveillance in psychiatry: a summary of inpatient data. Pharmacopsychiatry. 2004;37(suppl 1):S16-S26.doi:10.105/s-204-81507 PubMed
28. Engel RR, Grohmann R, Rüther E, et al. Research methods in drug surveillance. Pharmacopsychiatry. 2004;37(suppl 1):S12-S15.doi:10.105/s-204- 81506 PubMed
29. Grohmann R, Dirschedl P, Scherer J, et al. Reliability of adverse drug reaction assessment in psychiatric inpatients. Eur Arch Psychiatry Neurol Sci. 1985;235(3):158-163.doi:10.107/BF0380987 PubMed
30. Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binominal. Biometrika. 1934;26(4):404-413. doi:10.1093/biomet/26.4.404
31. Cooper JE. Pocket Guide to ICD-10 Classification of Mental and Behavioural Disorders: With Glossary and Diagnostic Criteria for Research DCR-10. London, United Kingdom: Churchill Livingstone; 1994.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
33. Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007;164(9):1356-1363.doi:10.176/api.ajp.207. 07030454 PubMed
34. Gualtieri CT. Paradoxical effects of fluoxetine. J Clin Psychopharmacol. 1991;11(6):393-394.doi:10.1097/04714-19120-02 PubMed
35. Healy D, Langmaak C, Savage M. Suicide in the course of the treatment of depression. J Psychopharmacol. 1999;13(1):94-99.doi:10.17/0269819013010 PubMed
36. Greil W, Horvath A, Sassim N, et al. Disinhibition of libido: an adverse effect of SSRI? J Affect Disord. 2001;62(3):225-228.doi:10.1016/S0165-0327(0) 0150-6 PubMed
37. Seemüller F, Riedel M, Obermeier M, et al. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode. Int J Neuropsychopharmacol. 2009;12(2):181-189.doi:10.1017/ S14614570809139 PubMed
38. Meyer JH, McMain S, Kennedy SH, et al. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry. 2003; 160(1):90-99.doi:10.176/api.ajp.160.1.90 PubMed